Skip to content

Preventing Post-Vaccination Presyncope and Syncope in Adolescents Using Simple, Clinic-based Interventions: A Pilot Study

Preventing Post-Vaccination Presyncope and Syncope in Adolescents Using Simple, Clinic-based Interventions: A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03533829
Enrollment
30
Registered
2018-05-23
Start date
2018-06-04
Completion date
2018-07-19
Last updated
2019-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Syncope, Vasovagal

Keywords

vaccination, pre-syncope, syncope prevention

Brief summary

This is a randomized controlled open-label trial. During the study, adolescents scheduled to receive at least one intramuscular (IM) vaccine will receive either Buzzy®, Music, or Buzzy® and Music intervention(s) in addition to standard care to evaluate the feasibility and acceptability of these interventions prior to being used in a larger study to assess the effectiveness of the interventions in preventing post-vaccination presyncope and syncope. Feasibility will be assessed according to study staff ability to successfully administer the protocol specified clinic-based interventions and per both study staff and healthcare provider responses to written feasibility assessments. Acceptability will be assessed according to the participant's self-report. In addition, baseline needle phobia and anxiety, post-vaccination pain and presyncope symptoms, and pre- and post- vaccination state anxiety will be assessed per participant written self-report to standardized survey questions.

Interventions

DEVICEBuzzy®

Buzzy® Drug Free Pain Relief which is a medical device designed to reduce vaccination pain when applied to the arm prior to and during a vaccination.

BEHAVIORALMusic

Music will be selected and listened to as a distraction before and during vaccination.

Sponsors

Centers for Disease Control and Prevention
CollaboratorFED
Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
10 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

1. 10 years through 17 years of age 2. If 10 through 13 years of age, the subject must be receiving at least one vaccine delivered intramuscularly 3. If 14 through 17 years of age, the subject must be receiving at least two injectable vaccines one of which must be delivered intramuscularly 4. The parent/guardian must be willing and capable of providing written informed consent for the adolescent and the adolescent must be willing and capable of providing assent. 5. The subject must be willing to stay for the completion of all study-related activities. 6. Parent/guardian and adolescent must speak and read English by self-report

Exclusion criteria

1. Receipt of investigational or experimental vaccine or medication within the previous two weeks 2. Receipt of routine injectable medication 3. Permanent indwelling venous catheter 4. Blood drawn within the past hour or scheduled for a blood draw during the post-vaccination observation period 5. Injection of medication during the past hour or scheduled for injection of medication during the observation period. 6. Cold intolerance or cold urticaria 7. Raynaud's phenomenon 8. Sickle cell disease 9. Inability to hear 10. Significant visual impairment or blindness 11. Febrile or acutely ill individuals 12. Upper arm or shoulder pain or injury 13. Adolescent or parent/Guardian is an immediate relative of study staff or an employee who is supervised by study staff. 14. Any condition that would, in the opinion of the site investigator, place the participant at an unacceptable risk of injury or render the participant unable to meet the requirements of the protocol

Design outcomes

Primary

MeasureTime frameDescription
Number of Subjects Who Found Having Buzzy® on Their Arm/s During Shot/s Somewhat Comfortable or Very ComfortableDay1Subjects will complete a survey about the acceptability of the Buzzy® intervention during their vaccinations
Number of Reports From Coordinators That Indicated Having Music Playing During the Vaccine Administration Was Somewhat Easy or Very EasyDay1Coordinators will answer a questionnaire about the feasibility of the music intervention after each encounter with a subject
Number of Subjects Who Have Buzzy® Applied to and Kept at Vaccination Site/s for ≥ 30 Seconds Prior to VaccinationDay1Buzzy® will be applied to and kept on the subjects arm for a minimum of 30 seconds prior to vaccination.
Number of Subjects Who Have Buzzy® Kept on Vaccination Arm/s During the Entire Vaccination ProcedureDay1Buzzy® will be applied to and kept on the subjects arm for the duration of the vaccination procedure.
Number of Subjects Who Have Music Playing for ≥ 3 Minutes Prior to VaccinationDay1Music will be played over speakers for a minimum of 3 minutes prior to vaccination
Number of Subjects Who Have Music Playing for 10 Minutes Post VaccinationDay1Music will be played over speakers through the 10 minute post vaccination pain assessment
Number of Subjects Who Complete the Pre-vaccination Anxiety AssessmentDay1Subjects will be asked to complete an anxiety assessment prior to vaccination
Number of Subjects Who Complete the Pre-vaccination Needle Phobia AssessmentDay1Subjects will be asked to complete a needle phobia assessment pre-vaccination
Number of Subjects Who Complete the Post-vaccination Pain Assessment at 1 Minute.Day1Subjects will complete a post vaccination pain assessment within one minute of their final vaccination
Number of Subjects Who Complete the Post-vaccination Pain Assessment at 10 MinutesDay1Subjects will complete a post vaccination pain assessment at 10 minutes after their final vaccination
Number of Subjects Who Complete the Post-vaccination Presyncope Symptom AssessmentDay1Subjects will complete a questionnaire about presyncope symptoms after their vaccination/s
Number of Subjects Who Complete the Post Vaccination Anxiety AssessmentDay1Subjects will complete a post vaccination anxiety assessment
Number of Subjects Who Complete the Acceptability AssessmentDay1Subjects will be given a questionnaire about the acceptability of their intervention.
Number of Reports From Coordinators That Indicated Having Music Playing During the Vaccine Administration Was Somewhat Assistive or Very AssistiveDay1Coordinators will answer a questionnaire about the feasibility of the music intervention after each encounter with a subject
Number of Reports From Coordinators That Indicated Having Buzzy® Applied in Conjunction With the Vaccination Was Somewhat Easy or Very EasyDay1Coordinators will answer a questionnaire about the feasibility of the Buzzy® intervention after each encounter with a subject
Number of Reports From Coordinators That Indicated Having Buzzy® Applied in Conjunction With the Vaccination Was Somewhat Assistive or Very AssistiveDay1Coordinators will answer a questionnaire about the feasibility of the Buzzy® intervention after each encounter with a subject
Number of Reports From Providers That Indicated Having Music Playing During the Vaccine Administration Was Somewhat Easy or Very EasyDay1Providers will answer a questionnaire about the feasibility of the music intervention after each encounter with a subject
Number of Reports From Providers That Indicated Having Music Playing During the Vaccine Administration Was Somewhat Assistive or Very AssistiveDay1Providers will answer a questionnaire about the feasibility of the music intervention after each encounter with a subject
Number of Reports From Providers That Indicated Having Buzzy® Applied in Conjunction With the Vaccination Was Somewhat Easy or Very EasyDay1Providers will answer a questionnaire about the feasibility of the Buzzy® intervention after each encounter with a subject
Number of Reports From Providers That Indicated Having Buzzy® Applied in Conjunction With the Vaccination Was Somewhat Assistive or Very AssistiveDay1Providers will answer a questionnaire about the feasibility of the Buzzy® intervention after each encounter with a subject
Number of Subjects Who Like Having Music Play During Their Shot/s a Little or Very MuchDay1Subjects will complete a survey about the acceptability of the music intervention during their vaccinations
Number of Subjects Who Felt Having Music Play During Their Shot/s Was Somewhat Easy or EasyDay1Subjects will complete a survey about the acceptability of the music intervention during their vaccinations
Number of Subjects Who Found Music Playing While Receiving Their Shots to be Somewhat Comfortable or Very ComfortableDay1Subjects will complete a survey about the acceptability of the music intervention during their vaccinations
Number of Subjects Who Found the Music Playing While They Got Their Shot/s to be Just RightDay1Subjects will complete a survey about the acceptability of the music intervention during their vaccinations
Number of Subjects Who Would be Somewhat Likely or Very Likely to Want to Listen to Music Again While Receiving Shot/sDay1Subjects will complete a survey about the acceptability of the music intervention during their vaccinations
Number of Subjects Who Found the Music App Sufficient or Somewhat Sufficient to Selecting the Music They LikeDay1Subjects will complete a survey about the acceptability of the music intervention during their vaccinations
Number of Subjects Who Either Like a Little or Very Much Liked Having Buzzy® on Their Arm/s During Shot/sDay1Subjects will complete a survey about the acceptability of the Buzzy® intervention during their vaccinations
Number of Subjects Who Found Having Buzzy® on Their Arm/s During Shot/s Somewhat Easy or Very EasyDay1Subjects will complete a survey about the acceptability of the Buzzy® intervention during their vaccinations
Number of Subjects Who Were Not Bothered by the Cold Temperature of Buzzy® on Their Arm/s During Shot/sDay1Subjects will complete a survey about the acceptability of the Buzzy® intervention during their vaccinations
Number of Subjects Who Were Not Bothered by the Vibration of Buzzy® on Their Arm/s During Shot/sDay1Subjects will complete a survey about the acceptability of the Buzzy® intervention during their vaccinations
Number of Subjects Who Would Choose to Have Buzzy® on Their Arm/s During Shot/s AgainDay1Subjects will complete a survey about the acceptability of the Buzzy® intervention during their vaccinations

Countries

United States

Participant flow

Participants by arm

ArmCount
Buzzy®
Buzzy® Drug Free Pain Relief which is a medical device designed to reduce vaccination pain when applied to the arm prior to and during a vaccination. Buzzy®: Buzzy® Drug Free Pain Relief which is a medical device designed to reduce vaccination pain when applied to the arm prior to and during a vaccination.
10
Music
Music will be selected and listened to as a distraction before and during vaccination. Music: Music will be selected and listened to as a distraction before and during vaccination.
10
Buzzy® and Music
Buzzy® will be applied to the arm prior to and during vaccination and music will be selected and listened to before and during vaccination. Buzzy®: Buzzy® Drug Free Pain Relief which is a medical device designed to reduce vaccination pain when applied to the arm prior to and during a vaccination. Music: Music will be selected and listened to as a distraction before and during vaccination.
10
Total30

Baseline characteristics

CharacteristicBuzzy®MusicBuzzy® and MusicTotal
Age, Customized
10-13 years
8 Participants6 Participants10 Participants24 Participants
Age, Customized
14-17 years
2 Participants4 Participants0 Participants6 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants0 Participants0 Participants1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
9 Participants10 Participants10 Participants29 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Race
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Race
Asian
0 Participants0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Race
Black or African American
2 Participants2 Participants2 Participants6 Participants
Race/Ethnicity, Customized
Race
More than one race
0 Participants0 Participants1 Participants1 Participants
Race/Ethnicity, Customized
Race
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Race
Other race
1 Participants0 Participants0 Participants1 Participants
Race/Ethnicity, Customized
Race
White
7 Participants8 Participants7 Participants22 Participants
Region of Enrollment
United States
10 Participants10 Participants10 Participants30 Participants
Sex: Female, Male
Female
3 Participants3 Participants4 Participants10 Participants
Sex: Female, Male
Male
7 Participants7 Participants6 Participants20 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 100 / 100 / 10
other
Total, other adverse events
0 / 101 / 100 / 10
serious
Total, serious adverse events
0 / 100 / 100 / 10

Outcome results

Primary

Number of Reports From Coordinators That Indicated Having Buzzy® Applied in Conjunction With the Vaccination Was Somewhat Assistive or Very Assistive

Coordinators will answer a questionnaire about the feasibility of the Buzzy® intervention after each encounter with a subject

Time frame: Day1

Population: Participant randomized to intervention and vaccinated

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Reports From Coordinators That Indicated Having Buzzy® Applied in Conjunction With the Vaccination Was Somewhat Assistive or Very Assistive9 Participants
MusicNumber of Reports From Coordinators That Indicated Having Buzzy® Applied in Conjunction With the Vaccination Was Somewhat Assistive or Very Assistive0 Participants
Buzzy® and MusicNumber of Reports From Coordinators That Indicated Having Buzzy® Applied in Conjunction With the Vaccination Was Somewhat Assistive or Very Assistive5 Participants
Primary

Number of Reports From Coordinators That Indicated Having Buzzy® Applied in Conjunction With the Vaccination Was Somewhat Easy or Very Easy

Coordinators will answer a questionnaire about the feasibility of the Buzzy® intervention after each encounter with a subject

Time frame: Day1

Population: Participant randomized to intervention and vaccinated

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Reports From Coordinators That Indicated Having Buzzy® Applied in Conjunction With the Vaccination Was Somewhat Easy or Very Easy9 Participants
MusicNumber of Reports From Coordinators That Indicated Having Buzzy® Applied in Conjunction With the Vaccination Was Somewhat Easy or Very Easy0 Participants
Buzzy® and MusicNumber of Reports From Coordinators That Indicated Having Buzzy® Applied in Conjunction With the Vaccination Was Somewhat Easy or Very Easy6 Participants
Primary

Number of Reports From Coordinators That Indicated Having Music Playing During the Vaccine Administration Was Somewhat Assistive or Very Assistive

Coordinators will answer a questionnaire about the feasibility of the music intervention after each encounter with a subject

Time frame: Day1

Population: Participant randomized to intervention and vaccinated

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Reports From Coordinators That Indicated Having Music Playing During the Vaccine Administration Was Somewhat Assistive or Very Assistive0 Participants
MusicNumber of Reports From Coordinators That Indicated Having Music Playing During the Vaccine Administration Was Somewhat Assistive or Very Assistive4 Participants
Buzzy® and MusicNumber of Reports From Coordinators That Indicated Having Music Playing During the Vaccine Administration Was Somewhat Assistive or Very Assistive3 Participants
Primary

Number of Reports From Coordinators That Indicated Having Music Playing During the Vaccine Administration Was Somewhat Easy or Very Easy

Coordinators will answer a questionnaire about the feasibility of the music intervention after each encounter with a subject

Time frame: Day1

Population: Participant randomized to intervention and vaccinated

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Reports From Coordinators That Indicated Having Music Playing During the Vaccine Administration Was Somewhat Easy or Very Easy0 Participants
MusicNumber of Reports From Coordinators That Indicated Having Music Playing During the Vaccine Administration Was Somewhat Easy or Very Easy5 Participants
Buzzy® and MusicNumber of Reports From Coordinators That Indicated Having Music Playing During the Vaccine Administration Was Somewhat Easy or Very Easy6 Participants
Primary

Number of Reports From Providers That Indicated Having Buzzy® Applied in Conjunction With the Vaccination Was Somewhat Assistive or Very Assistive

Providers will answer a questionnaire about the feasibility of the Buzzy® intervention after each encounter with a subject

Time frame: Day1

Population: Participant randomized to intervention and vaccinated

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Reports From Providers That Indicated Having Buzzy® Applied in Conjunction With the Vaccination Was Somewhat Assistive or Very Assistive7 Participants
MusicNumber of Reports From Providers That Indicated Having Buzzy® Applied in Conjunction With the Vaccination Was Somewhat Assistive or Very Assistive0 Participants
Buzzy® and MusicNumber of Reports From Providers That Indicated Having Buzzy® Applied in Conjunction With the Vaccination Was Somewhat Assistive or Very Assistive7 Participants
Primary

Number of Reports From Providers That Indicated Having Buzzy® Applied in Conjunction With the Vaccination Was Somewhat Easy or Very Easy

Providers will answer a questionnaire about the feasibility of the Buzzy® intervention after each encounter with a subject

Time frame: Day1

Population: Participant randomized to intervention and vaccinated. One participant did not complete the assessment.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Reports From Providers That Indicated Having Buzzy® Applied in Conjunction With the Vaccination Was Somewhat Easy or Very Easy6 Participants
MusicNumber of Reports From Providers That Indicated Having Buzzy® Applied in Conjunction With the Vaccination Was Somewhat Easy or Very Easy0 Participants
Buzzy® and MusicNumber of Reports From Providers That Indicated Having Buzzy® Applied in Conjunction With the Vaccination Was Somewhat Easy or Very Easy8 Participants
Primary

Number of Reports From Providers That Indicated Having Music Playing During the Vaccine Administration Was Somewhat Assistive or Very Assistive

Providers will answer a questionnaire about the feasibility of the music intervention after each encounter with a subject

Time frame: Day1

Population: Participant randomized to intervention and vaccinated. One participant did not complete the assessment.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Reports From Providers That Indicated Having Music Playing During the Vaccine Administration Was Somewhat Assistive or Very Assistive0 Participants
MusicNumber of Reports From Providers That Indicated Having Music Playing During the Vaccine Administration Was Somewhat Assistive or Very Assistive6 Participants
Buzzy® and MusicNumber of Reports From Providers That Indicated Having Music Playing During the Vaccine Administration Was Somewhat Assistive or Very Assistive7 Participants
Primary

Number of Reports From Providers That Indicated Having Music Playing During the Vaccine Administration Was Somewhat Easy or Very Easy

Providers will answer a questionnaire about the feasibility of the music intervention after each encounter with a subject

Time frame: Day1

Population: Participant randomized to intervention and vaccinated. One participant did not complete the assessment.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Reports From Providers That Indicated Having Music Playing During the Vaccine Administration Was Somewhat Easy or Very Easy0 Participants
MusicNumber of Reports From Providers That Indicated Having Music Playing During the Vaccine Administration Was Somewhat Easy or Very Easy7 Participants
Buzzy® and MusicNumber of Reports From Providers That Indicated Having Music Playing During the Vaccine Administration Was Somewhat Easy or Very Easy8 Participants
Primary

Number of Subjects Who Complete the Acceptability Assessment

Subjects will be given a questionnaire about the acceptability of their intervention.

Time frame: Day1

Population: Participant randomized to intervention and vaccinated

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Subjects Who Complete the Acceptability Assessment10 Participants
MusicNumber of Subjects Who Complete the Acceptability Assessment10 Participants
Buzzy® and MusicNumber of Subjects Who Complete the Acceptability Assessment10 Participants
Primary

Number of Subjects Who Complete the Post Vaccination Anxiety Assessment

Subjects will complete a post vaccination anxiety assessment

Time frame: Day1

Population: Participant randomized to intervention and vaccinated

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Subjects Who Complete the Post Vaccination Anxiety Assessment10 Participants
MusicNumber of Subjects Who Complete the Post Vaccination Anxiety Assessment10 Participants
Buzzy® and MusicNumber of Subjects Who Complete the Post Vaccination Anxiety Assessment10 Participants
Primary

Number of Subjects Who Complete the Post-vaccination Pain Assessment at 10 Minutes

Subjects will complete a post vaccination pain assessment at 10 minutes after their final vaccination

Time frame: Day1

Population: Participants randomized to intervention and vaccinated.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Subjects Who Complete the Post-vaccination Pain Assessment at 10 Minutes8 Participants
MusicNumber of Subjects Who Complete the Post-vaccination Pain Assessment at 10 Minutes10 Participants
Buzzy® and MusicNumber of Subjects Who Complete the Post-vaccination Pain Assessment at 10 Minutes9 Participants
Primary

Number of Subjects Who Complete the Post-vaccination Pain Assessment at 1 Minute.

Subjects will complete a post vaccination pain assessment within one minute of their final vaccination

Time frame: Day1

Population: Participants randomized to intervention and vaccinated.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Subjects Who Complete the Post-vaccination Pain Assessment at 1 Minute.4 Participants
MusicNumber of Subjects Who Complete the Post-vaccination Pain Assessment at 1 Minute.7 Participants
Buzzy® and MusicNumber of Subjects Who Complete the Post-vaccination Pain Assessment at 1 Minute.3 Participants
Primary

Number of Subjects Who Complete the Post-vaccination Presyncope Symptom Assessment

Subjects will complete a questionnaire about presyncope symptoms after their vaccination/s

Time frame: Day1

Population: Participants randomized to intervention and vaccinated.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Subjects Who Complete the Post-vaccination Presyncope Symptom Assessment10 Participants
MusicNumber of Subjects Who Complete the Post-vaccination Presyncope Symptom Assessment10 Participants
Buzzy® and MusicNumber of Subjects Who Complete the Post-vaccination Presyncope Symptom Assessment10 Participants
Primary

Number of Subjects Who Complete the Pre-vaccination Anxiety Assessment

Subjects will be asked to complete an anxiety assessment prior to vaccination

Time frame: Day1

Population: Participants randomized to intervention and vaccinated

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Subjects Who Complete the Pre-vaccination Anxiety Assessment10 Participants
MusicNumber of Subjects Who Complete the Pre-vaccination Anxiety Assessment10 Participants
Buzzy® and MusicNumber of Subjects Who Complete the Pre-vaccination Anxiety Assessment10 Participants
Primary

Number of Subjects Who Complete the Pre-vaccination Needle Phobia Assessment

Subjects will be asked to complete a needle phobia assessment pre-vaccination

Time frame: Day1

Population: Participant randomized to intervention and vaccinated

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Subjects Who Complete the Pre-vaccination Needle Phobia Assessment10 Participants
MusicNumber of Subjects Who Complete the Pre-vaccination Needle Phobia Assessment10 Participants
Buzzy® and MusicNumber of Subjects Who Complete the Pre-vaccination Needle Phobia Assessment10 Participants
Primary

Number of Subjects Who Either Like a Little or Very Much Liked Having Buzzy® on Their Arm/s During Shot/s

Subjects will complete a survey about the acceptability of the Buzzy® intervention during their vaccinations

Time frame: Day1

Population: Participants randomized to intervention and vaccinated

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Subjects Who Either Like a Little or Very Much Liked Having Buzzy® on Their Arm/s During Shot/s9 Participants
MusicNumber of Subjects Who Either Like a Little or Very Much Liked Having Buzzy® on Their Arm/s During Shot/s0 Participants
Buzzy® and MusicNumber of Subjects Who Either Like a Little or Very Much Liked Having Buzzy® on Their Arm/s During Shot/s9 Participants
Primary

Number of Subjects Who Felt Having Music Play During Their Shot/s Was Somewhat Easy or Easy

Subjects will complete a survey about the acceptability of the music intervention during their vaccinations

Time frame: Day1

Population: Participant randomized to intervention and vaccinated

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Subjects Who Felt Having Music Play During Their Shot/s Was Somewhat Easy or Easy0 Participants
MusicNumber of Subjects Who Felt Having Music Play During Their Shot/s Was Somewhat Easy or Easy9 Participants
Buzzy® and MusicNumber of Subjects Who Felt Having Music Play During Their Shot/s Was Somewhat Easy or Easy10 Participants
Primary

Number of Subjects Who Found Having Buzzy® on Their Arm/s During Shot/s Somewhat Comfortable or Very Comfortable

Subjects will complete a survey about the acceptability of the Buzzy® intervention during their vaccinations

Time frame: Day1

Population: Participants randomized to intervention and vaccinated

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Subjects Who Found Having Buzzy® on Their Arm/s During Shot/s Somewhat Comfortable or Very Comfortable7 Participants
MusicNumber of Subjects Who Found Having Buzzy® on Their Arm/s During Shot/s Somewhat Comfortable or Very Comfortable0 Participants
Buzzy® and MusicNumber of Subjects Who Found Having Buzzy® on Their Arm/s During Shot/s Somewhat Comfortable or Very Comfortable8 Participants
Primary

Number of Subjects Who Found Having Buzzy® on Their Arm/s During Shot/s Somewhat Easy or Very Easy

Subjects will complete a survey about the acceptability of the Buzzy® intervention during their vaccinations

Time frame: Day1

Population: Participant randomized to intervention and vaccinated

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Subjects Who Found Having Buzzy® on Their Arm/s During Shot/s Somewhat Easy or Very Easy10 Participants
MusicNumber of Subjects Who Found Having Buzzy® on Their Arm/s During Shot/s Somewhat Easy or Very Easy0 Participants
Buzzy® and MusicNumber of Subjects Who Found Having Buzzy® on Their Arm/s During Shot/s Somewhat Easy or Very Easy9 Participants
Primary

Number of Subjects Who Found Music Playing While Receiving Their Shots to be Somewhat Comfortable or Very Comfortable

Subjects will complete a survey about the acceptability of the music intervention during their vaccinations

Time frame: Day1

Population: Participants randomized to intervention and vaccinated. One participant did not complete the assessment.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Subjects Who Found Music Playing While Receiving Their Shots to be Somewhat Comfortable or Very Comfortable0 Participants
MusicNumber of Subjects Who Found Music Playing While Receiving Their Shots to be Somewhat Comfortable or Very Comfortable10 Participants
Buzzy® and MusicNumber of Subjects Who Found Music Playing While Receiving Their Shots to be Somewhat Comfortable or Very Comfortable9 Participants
Primary

Number of Subjects Who Found the Music App Sufficient or Somewhat Sufficient to Selecting the Music They Like

Subjects will complete a survey about the acceptability of the music intervention during their vaccinations

Time frame: Day1

Population: Participant randomized to intervention and vaccinated

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Subjects Who Found the Music App Sufficient or Somewhat Sufficient to Selecting the Music They Like0 Participants
MusicNumber of Subjects Who Found the Music App Sufficient or Somewhat Sufficient to Selecting the Music They Like10 Participants
Buzzy® and MusicNumber of Subjects Who Found the Music App Sufficient or Somewhat Sufficient to Selecting the Music They Like10 Participants
Primary

Number of Subjects Who Found the Music Playing While They Got Their Shot/s to be Just Right

Subjects will complete a survey about the acceptability of the music intervention during their vaccinations

Time frame: Day1

Population: Participants randomized to intervention and vaccinated

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Subjects Who Found the Music Playing While They Got Their Shot/s to be Just Right0 Participants
MusicNumber of Subjects Who Found the Music Playing While They Got Their Shot/s to be Just Right10 Participants
Buzzy® and MusicNumber of Subjects Who Found the Music Playing While They Got Their Shot/s to be Just Right8 Participants
Primary

Number of Subjects Who Have Buzzy® Applied to and Kept at Vaccination Site/s for ≥ 30 Seconds Prior to Vaccination

Buzzy® will be applied to and kept on the subjects arm for a minimum of 30 seconds prior to vaccination.

Time frame: Day1

Population: Participants randomized to intervention and vaccinated

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Subjects Who Have Buzzy® Applied to and Kept at Vaccination Site/s for ≥ 30 Seconds Prior to Vaccination10 Participants
MusicNumber of Subjects Who Have Buzzy® Applied to and Kept at Vaccination Site/s for ≥ 30 Seconds Prior to Vaccination0 Participants
Buzzy® and MusicNumber of Subjects Who Have Buzzy® Applied to and Kept at Vaccination Site/s for ≥ 30 Seconds Prior to Vaccination10 Participants
Primary

Number of Subjects Who Have Buzzy® Kept on Vaccination Arm/s During the Entire Vaccination Procedure

Buzzy® will be applied to and kept on the subjects arm for the duration of the vaccination procedure.

Time frame: Day1

Population: Participants randomized to intervention and vaccinated

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Subjects Who Have Buzzy® Kept on Vaccination Arm/s During the Entire Vaccination Procedure9 Participants
MusicNumber of Subjects Who Have Buzzy® Kept on Vaccination Arm/s During the Entire Vaccination Procedure0 Participants
Buzzy® and MusicNumber of Subjects Who Have Buzzy® Kept on Vaccination Arm/s During the Entire Vaccination Procedure10 Participants
Primary

Number of Subjects Who Have Music Playing for 10 Minutes Post Vaccination

Music will be played over speakers through the 10 minute post vaccination pain assessment

Time frame: Day1

Population: Participants randomized to intervention and vaccinated

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Subjects Who Have Music Playing for 10 Minutes Post Vaccination0 Participants
MusicNumber of Subjects Who Have Music Playing for 10 Minutes Post Vaccination8 Participants
Buzzy® and MusicNumber of Subjects Who Have Music Playing for 10 Minutes Post Vaccination7 Participants
Primary

Number of Subjects Who Have Music Playing for ≥ 3 Minutes Prior to Vaccination

Music will be played over speakers for a minimum of 3 minutes prior to vaccination

Time frame: Day1

Population: Participants randomized to intervention and vaccinated

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Subjects Who Have Music Playing for ≥ 3 Minutes Prior to Vaccination0 Participants
MusicNumber of Subjects Who Have Music Playing for ≥ 3 Minutes Prior to Vaccination10 Participants
Buzzy® and MusicNumber of Subjects Who Have Music Playing for ≥ 3 Minutes Prior to Vaccination10 Participants
Primary

Number of Subjects Who Like Having Music Play During Their Shot/s a Little or Very Much

Subjects will complete a survey about the acceptability of the music intervention during their vaccinations

Time frame: Day1

Population: Participant randomized to intervention and vaccinated

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Subjects Who Like Having Music Play During Their Shot/s a Little or Very Much0 Participants
MusicNumber of Subjects Who Like Having Music Play During Their Shot/s a Little or Very Much9 Participants
Buzzy® and MusicNumber of Subjects Who Like Having Music Play During Their Shot/s a Little or Very Much9 Participants
Primary

Number of Subjects Who Were Not Bothered by the Cold Temperature of Buzzy® on Their Arm/s During Shot/s

Subjects will complete a survey about the acceptability of the Buzzy® intervention during their vaccinations

Time frame: Day1

Population: Participants randomized to intervention and vaccinated

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Subjects Who Were Not Bothered by the Cold Temperature of Buzzy® on Their Arm/s During Shot/s6 Participants
MusicNumber of Subjects Who Were Not Bothered by the Cold Temperature of Buzzy® on Their Arm/s During Shot/s0 Participants
Buzzy® and MusicNumber of Subjects Who Were Not Bothered by the Cold Temperature of Buzzy® on Their Arm/s During Shot/s8 Participants
Primary

Number of Subjects Who Were Not Bothered by the Vibration of Buzzy® on Their Arm/s During Shot/s

Subjects will complete a survey about the acceptability of the Buzzy® intervention during their vaccinations

Time frame: Day1

Population: Participants randomized to intervention and vaccinated

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Subjects Who Were Not Bothered by the Vibration of Buzzy® on Their Arm/s During Shot/s10 Participants
MusicNumber of Subjects Who Were Not Bothered by the Vibration of Buzzy® on Their Arm/s During Shot/s0 Participants
Buzzy® and MusicNumber of Subjects Who Were Not Bothered by the Vibration of Buzzy® on Their Arm/s During Shot/s9 Participants
Primary

Number of Subjects Who Would be Somewhat Likely or Very Likely to Want to Listen to Music Again While Receiving Shot/s

Subjects will complete a survey about the acceptability of the music intervention during their vaccinations

Time frame: Day1

Population: Participants randomized to intervention and vaccinated

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Subjects Who Would be Somewhat Likely or Very Likely to Want to Listen to Music Again While Receiving Shot/s0 Participants
MusicNumber of Subjects Who Would be Somewhat Likely or Very Likely to Want to Listen to Music Again While Receiving Shot/s10 Participants
Buzzy® and MusicNumber of Subjects Who Would be Somewhat Likely or Very Likely to Want to Listen to Music Again While Receiving Shot/s10 Participants
Primary

Number of Subjects Who Would Choose to Have Buzzy® on Their Arm/s During Shot/s Again

Subjects will complete a survey about the acceptability of the Buzzy® intervention during their vaccinations

Time frame: Day1

Population: Participants randomized to intervention and vaccinated

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Buzzy®Number of Subjects Who Would Choose to Have Buzzy® on Their Arm/s During Shot/s Again9 Participants
MusicNumber of Subjects Who Would Choose to Have Buzzy® on Their Arm/s During Shot/s Again0 Participants
Buzzy® and MusicNumber of Subjects Who Would Choose to Have Buzzy® on Their Arm/s During Shot/s Again8 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026